Neha Krishnamohan's Net Worth
$201 Thousand
Who is Neha Krishnamohan?
Neha Krishnamohan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Kinnate Biopharma Inc., Arcutis Biotherapeutics, Inc., and Artiva Biotherapeutics, Inc..
SEC CIK
Neha Krishnamohan's CIK is 0001866171
Past Insider Trading and Trends
2022 was Neha Krishnamohan's most active year for acquiring shares with 3 total transactions. Neha Krishnamohan's most active month to acquire stocks was the month of May. 2024 was Neha Krishnamohan's most active year for disposing of shares, totalling 5 transactions. Neha Krishnamohan's most active month to dispose stocks was the month of March. 2021 saw Neha Krishnamohan paying a total of $0.00 for 270,000 shares, this is the most they've acquired in one year. In 2022 Neha Krishnamohan cashed out on 1,459 shares for a total of $11,307.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kinnate Biopharma Inc. (KNTE) No price found
CHIEF FINANCIAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -64.09K |
—
|
—
|
0
|
Apr 3
| |||
Form 4
| -2.30% | -1.51K |
$2.59 | -$3,900.54 | 64.09K |
Mar 1
| |||
Form 4
| -2.18% | -1.46K |
$2.25 | -$3,282.75 | 65.59K |
Dec 1
| |||
Form 4
| -2.13% | -1.46K |
$2.35 | -$3,428.65 | 67.05K |
Sep 1
| |||
Form 4
| -2.09% | -1.46K |
$4.30 | -$6,273.70 | 68.51K |
Jun 1
| |||
Form 4
| -2.49% | -1.72K |
$5.21 | -$8,966.41 | 67.38K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| -2.07% | -1.46K |
$7.75 | -$11,307.25 | 69.1K |
Dec 1
| |||
Form 4
| +4,455.45% | 67.5K |
—
|
—
| 69.02K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcutis Biotherapeutics, Inc. (ARQT) Snapshot price: $10.38
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +180.83% | 10.14K |
—
|
—
| 15.75K |
Jun 14
| |||
Form 4
| +355.11% | 4.38K |
—
|
—
| 5.61K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Artiva Biotherapeutics, Inc. (ARTV) No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Sep 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||